Status: retired, Primitive. Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3773226014 | Product containing only goserelin in subcutaneous dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3773227017 | Goserelin only product in subcutaneous dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Goserelin only product in subcutaneous dose form | Is a | Goserelin-containing product in subcutaneous dose form | false | Inferred relationship | Some | ||
| Goserelin only product in subcutaneous dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Goserelin only product in subcutaneous dose form | Has manufactured dose form | Subcutaneous dose form | false | Inferred relationship | Some | ||
| Goserelin only product in subcutaneous dose form | Is a | Goserelin only product in parenteral dose form | false | Inferred relationship | Some | ||
| Goserelin only product in subcutaneous dose form | Has active ingredient | Goserelin | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant | Is a | False | Goserelin only product in subcutaneous dose form | Inferred relationship | Some | |
| Goserelin (as goserelin acetate) 3.6 mg prolonged-release subcutaneous implant | Is a | False | Goserelin only product in subcutaneous dose form | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR